Archive

Rating: 3.5-4 / 10 Though the life sciences sector is yet to see ‘radical reforms’, the Narendra Modi Government’s efforts to…

Rating: 2.5/ 10 It is too early to be measure the impact that the new Government has had on the economy and markets. The Prime…

Sankar Sundaram, pharmaceutical sciences professor at JSS University, Mysore and a patent agent with India's intellectual property…

Training will help the channel partners from India and other parts of Asia to understand the technology

The Ebola outbreak has become a global emergency today. While a few drugs and vaccines are still under trial, the news of possible…

Low investor sentiment, regulatory hurdles, drying pipelines are some of the challenges facing the biotech sector. It remains to…

Gujarat State Biotechnology Mission (GSBTM), a state-level nodal agency, coordinates the activities programme for encouraging and…

Excerpts from a white paper that examines India’s biotech industry from different perspectives, with focus on biopharma and…

Merck Serono to enhance its access to antibody drug conjugate technologies and to expand its oncology pipeline

Silver Leaf will acquire the stake from Biocon Research Limited (BRL), a wholly-owned subsidiary of Biocon at a valuation of Rs…

Commit to control and eliminate vector-borne diseases

To enter Czech Republic and Slovakia with affordable high quality alternatives

To market meropenem in three European countries

Roche to fully acquire InterMune at a price of $74.00 per share

WCK 771 is an intravenous (IV) drug while WCK 2349 is a solid oral tablet

IPEC India is the fifth member of the IPEC Federation

As per agreement, NITD will fully transfer its TB R&D programme to TB Alliance

Cipla has granted Salix exclusive rights under certain patent applications in the ‘Rifaximin Complexes’ patent family

Indian pharma sector witnesses no deals during August 2014

The event in Bangalore will discuss about the importance of investing in biotechnology in India